Lidia Staszewsky Selected Research

Lidia Staszewsky Research Topics

Disease

19	Heart Failure 01/2022 - 04/2002
9	Myocardial Infarction 01/2022 - 07/2003
8	Heart Arrest (Cardiac Arrest) 12/2021 - 11/2013
6	Atrial Fibrillation 11/2021 - 01/2006
5	Neoplasms (Cancer) 03/2022 - 11/2008
4	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 01/2006
4	Left Ventricular Dysfunction 01/2018 - 10/2004
3	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 12/2007
3	Diabetes Mellitus 01/2022 - 08/2011
3	Infarction (Infarctions) 12/2020 - 10/2015
3	Brain Injuries (Brain Injury) 12/2020 - 01/2014
3	Hypertension (High Blood Pressure) 11/2013 - 08/2011
3	Ventricular Remodeling 12/2006 - 07/2003
2	Ventricular Fibrillation 01/2021 - 08/2014
2	Cardiotoxicity 01/2020 - 01/2018
2	Type 2 Diabetes Mellitus (MODY) 01/2018 - 11/2013
2	Cardiac Arrhythmias (Arrythmia) 09/2014 - 04/2009
2	Atrial Remodeling 11/2011 - 04/2009
1	Renal Insufficiency (Renal Failure) 01/2022
1	Familial Primary Pulmonary Hypertension 07/2021
1	Obesity 01/2021
1	Ventricular Dysfunction 01/2021
1	Death (Near-Death Experience) 01/2021
1	Necrosis 01/2021
1	Overweight 01/2021
1	Splenomegaly 08/2020
1	Colonic Neoplasms (Colon Cancer) 08/2020
1	Cachexia 08/2020
1	Inflammation (Inflammations) 08/2020
1	Heart Diseases (Heart Disease) 01/2020
1	Pulmonary Hypertension 12/2019
1	Pulmonary Arterial Hypertension 12/2019
1	Sudden Death 01/2019
1	Hypercapnia 01/2019
1	ST Elevation Myocardial Infarction 05/2014
1	Cardiogenic Shock 05/2014
1	Neurologic Manifestations (Neurological Manifestations) 01/2014
1	Glucose Intolerance 11/2013
1	Body Weight (Weight, Body) 11/2013
1	Hemorrhage 04/2013
1	Stroke (Strokes) 08/2011

Drug/Important Bio-Agent (IBA)

9	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2006
9	Valsartan (Vals)FDA Link 11/2013 - 04/2002
4	pro-brain natriuretic peptide (1-76)IBA 01/2022 - 01/2021
4	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2022 - 01/2006
3	Insulin (Novolin)FDA Link 01/2022 - 01/2018
3	KynurenineIBA 12/2021 - 11/2013
3	ArgonIBA 07/2021 - 01/2014
3	TroponinIBA 12/2020 - 01/2018
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2008 - 09/2002
2	Troponin T (Troponin T1)IBA 01/2022 - 01/2022
2	Epinephrine (Adrenaline)FDA LinkGeneric 01/2021 - 08/2014
2	AnthracyclinesIBA 01/2020 - 01/2018
2	Enalapril FDA LinkGeneric 01/2020 - 01/2018
2	Glucose (Dextrose)FDA LinkGeneric 01/2018 - 11/2013
2	AldosteroneIBA 01/2012 - 10/2004
2	Natriuretic PeptidesIBA 01/2012 - 12/2006
2	Angiotensin Receptor AntagonistsIBA 04/2009 - 09/2002
2	Lisinopril (Prinivil)FDA LinkGeneric 02/2008 - 07/2003
1	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 03/2022
1	Pharmaceutical PreparationsIBA 03/2022
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2022
1	Trinitrotoluene (TNT)IBA 01/2022
1	esmolol (Brevibloc)FDA LinkGeneric 01/2021
1	insulin-like growth factor binding protein-related protein 1IBA 01/2021
1	Neuroprotective AgentsIBA 12/2020
1	Macrophage Colony-Stimulating FactorIBA 08/2020
1	Interleukin-6 (Interleukin 6)IBA 08/2020
1	CytokinesIBA 08/2020
1	PM 01183IBA 08/2020
1	TrabectedinIBA 08/2020
1	trans-crotonin (CTN)IBA 01/2020
1	MonocrotalineIBA 12/2019
1	Endothelin Receptor AntagonistsIBA 12/2019
1	rho-Associated KinasesIBA 12/2019
1	Protein Kinases (Protein Kinase)IBA 12/2019
1	Y 27632IBA 12/2019
1	macitentanIBA 12/2019
1	Vasoconstrictor AgentsIBA 12/2019
1	SodiumIBA 01/2019
1	Cyclosporine (Ciclosporin)FDA LinkGeneric 02/2016
1	Bronchodilator Agents (Bronchodilators)IBA 01/2016
1	Ranolazine FDA Link 09/2014
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2014
1	Heparin (Liquaemin)FDA LinkGeneric 05/2014
1	omega-Chloroacetophenone (Mace)IBA 05/2014
1	Fondaparinux (Arixtra)FDA Link 05/2014
1	Phosphopyruvate Hydratase (Enolase)IBA 01/2014
1	Nateglinide (Starlix)FDA LinkGeneric 11/2013
1	Warfarin (Coumadin)FDA LinkGeneric 04/2013
1	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 02/2013
1	candesartanIBA 01/2012
1	Calcium Channel Blockers (Blockers, Calcium Channel)IBA 08/2011
1	Amiodarone (Amiodarona)FDA LinkGeneric 08/2011

Therapy/Procedure

9	Therapeutics 01/2022 - 09/2002
5	Cardiopulmonary Resuscitation (CPR) 01/2021 - 08/2014
4	Resuscitation 12/2020 - 11/2013
3	Drug Therapy (Chemotherapy) 01/2020 - 11/2008
3	Electric Countershock (Cardioversion) 11/2011 - 01/2006
2	Percutaneous Coronary Intervention 02/2016 - 10/2015